bioAffinity Technologies, Inc.
BIAF
$0.245
$0.0062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.80% | -16.40% | -13.89% | -16.68% | 11.46% |
| Total Depreciation and Amortization | 12.94% | 61.71% | 142.53% | 455.27% | 886.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.96% | 18.02% | 32.17% | 79.66% | -71.67% |
| Change in Net Operating Assets | 572.62% | 492.74% | -80.05% | -145.03% | 143.80% |
| Cash from Operations | -9.22% | 4.29% | -20.32% | -25.90% | -18.11% |
| Capital Expenditure | -30.27% | -175.70% | -243.91% | 74.38% | 77.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.72% | 96.01% | 96.42% | 97.31% | -775.49% |
| Total Debt Issued | 515.67% | 492.42% | -- | -- | -96.37% |
| Total Debt Repaid | -55.13% | -17.47% | -4.67% | 56.91% | 60.88% |
| Issuance of Common Stock | 213.56% | 89.84% | -- | -- | -81.36% |
| Repurchase of Common Stock | -- | -- | -- | -247,350.00% | -247,350.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -- | -- | -100.00% |
| Cash from Financing | 332.44% | 164.08% | 1,731.22% | 526.92% | -87.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.02% | 72.55% | 80.02% | 58.25% | -192.72% |